Drug Trial Radar · NCT00107887
TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)
Last checked: Nov 19, 2026Latest source record: Jun 15, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
17,415
Actual
Start
Jun 2005
Primary completion
Dec 2010
Study completion Dec 2010
Sponsor
- Lead sponsor
- Johns Hopkins UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Consortium to Respond Effectively to the AIDS/Tuberculosis Epidemic; Communicable Disease Program, Brazil; Bill and Melinda Gates Foundation
- First posted
- Apr 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if implementing a policy of widespread INH (Isoniazid) prophylaxis therapy in HIV-infected patients with access to antiretroviral therapy reduces the incidence of active TB disease in the HIV clinic population.
Conditions
- Tuberculosis
- HIV Infections
Interventions
INH preventive therapyDrug
Clinics will receive training regarding the use of IPT for prevention of Tuberculosis
TST (tuberculin skin test)Drug
Clinics will be trained in the use of TST for assessing exposure to TB
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measured incidence of active TB in HIV clinic population before and following implementation of IPT policyTime frame: 6 Years
- Comparative impact of IPT (Isoniazid Preventive Therapy) and ARVs (antiretrovirals) on TB incidence in the HIV clinic populationTime frame: 6 Years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
City of Rio De Janeiro Health Department Clinics
Rio de Janeiro, Rio de Janeiro, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.